tiprankstipranks
Advertisement
Advertisement
Waldencast price target lowered to $2 from $4 at Canaccord
PremiumThe FlyWaldencast price target lowered to $2 from $4 at Canaccord
1M ago
Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive
Premium
Company Announcements
Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive
1M ago
Waldencast reports Q4 revenue $72M vs. $72.1M last year
Premium
The Fly
Waldencast reports Q4 revenue $72M vs. $72.1M last year
1M ago
Obagi Medical, Moxie collaborate for ALOHA program
PremiumThe FlyObagi Medical, Moxie collaborate for ALOHA program
2M ago
Obagi Medical, VIO Med Spa announce collaboration in ALOHA program
Premium
The Fly
Obagi Medical, VIO Med Spa announce collaboration in ALOHA program
2M ago
Obagi Medical, Next Health collaborate for ALOHA program
Premium
The Fly
Obagi Medical, Next Health collaborate for ALOHA program
3M ago
Waldencast assumed with a Buy at Jefferies
PremiumThe FlyWaldencast assumed with a Buy at Jefferies
3M ago
Waldencast Sets January 2026 AGM and Reshapes Board Following Director Resignations
Premium
Company Announcements
Waldencast Sets January 2026 AGM and Reshapes Board Following Director Resignations
4M ago
Waldencast files to sell 9.82M Class A ordinary shares for holders
Premium
The Fly
Waldencast files to sell 9.82M Class A ordinary shares for holders
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100